Heart failure is a major public health concern, a disease that affects tens of millions of people around the world—forcing many into a vicious cycle of hospitalizations, discharges and frequent readmissions.
Weight-loss drug Wegovy (semaglutide) and its diabetes-focused cousin, Ozempic, have already upended the treatment of both obesity and diabetes, with sales of both drugs skyrocketing.
Aug 26, 2023
0
38
An Australian research team led by QIMR Berghofer has succeeded in introducing a vascular system into tiny living and beating model human heart muscles, an achievement which it's hoped will accelerate progress toward the ...
Apr 27, 2023
0
101
Physician-scientists at The Texas Heart Institute announced today the results of the largest cell therapy trial to date in patients with chronic heart failure due to low ejection fraction. The therapy benefited patients by ...
Feb 27, 2023
0
410
A new study from researchers at the Johns Hopkins Bloomberg School of Public Health found that people who smoked tobacco cigarettes developed heart failure at twice the rate of those who never smoked. This higher rate occurred ...
Jun 8, 2022
0
200
Dapagliflozin, a drug commonly used to treat type 2 diabetes, improved symptoms and physical limitations in patients with heart failure with preserved ejection fraction, according to clinical trial results published in Nature ...
Nov 30, 2021
0
55
A special artificial intelligence (AI)-based computer algorithm created by Mount Sinai researchers was able to learn how to identify subtle changes in electrocardiograms (also known as ECGs or EKGs) to predict whether a patient ...
Oct 19, 2021
0
101
A year of exercise training helped to preserve or increase the youthful elasticity of the heart muscle among people showing early signs of heart failure, a small study shows.
Sep 21, 2021
1
216
An early phase trial of a drug currently used to treat lung fibrosis has shown it may also help patients who suffer from a common form of heart failure.
Aug 13, 2021
0
441
A medication used to treat diabetes is able to reduce hospitalizations and cardiovascular deaths in patients with heart failure by 33 percent, suggests a recent study published in the New England Journal of Medicine.
Nov 18, 2020
0
66
